Risk Factors for Extrapyramidal Symptoms During Treatment With Selective Serotonin Reuptake Inhibitors, Including Cytochrome P-450 Enzyme, and Serotonin and Dopamine Transporter and Receptor Polymorphisms

Arya, 1994, Extrapyramidal symptoms with selective serotonin reuptake inhibitors., Br J Psychiatry, 165, 728, 10.1192/bjp.165.6.728

Leo, 1996, Movement disorders associated with the serotonin selective reuptake inhibitors., J Clin Psychiatry, 57, 449, 10.4088/JCP.v57n1002

Damsa, 2004, "Dopamine-dependent" side effects of selective serotonin reuptake inhibitors: a clinical review., J Clin Psychiatry, 65, 1064, 10.4088/JCP.v65n0806

Arya, 1997, Existing brain condition may predispose to SSRI-induced extrapyramidal symptoms., Aust N Z J Psychiatry, 31, 773

Lane, 1998, SSRI-induced extrapyramidal side-effects and akathisia: implications for treatment., J Psychopharmacol, 12, 192, 10.1177/026988119801200212

Caley, 1997, Extrapyramidal reactions and the selective serotonin-reuptake inhibitors., Ann Pharmacother, 31, 1481, 10.1177/106002809703101208

Arya, 1995, Exacerbation of extrapyramidal symptoms with paroxetine., Aust N Z J Psychiatry, 29, 521

Guzey, 2004, Genotyping as a tool to predict adverse drug reactions., Curr Top Med Chem, 4, 1411, 10.2174/1568026043387791

Perlis, 2003, Serotonin transporter polymorphisms and adverse effects with fluoxetine treatment., Biol Psychiatry, 54, 879, 10.1016/S0006-3223(03)00424-4

Murphy, 2004, Effects of the serotonin transporter gene promoter polymorphism on mirtazapine and paroxetine efficacy and adverse events in geriatric major depression., Arch Gen Psychiatry, 61, 1163, 10.1001/archpsyc.61.11.1163

Murphy, 2003, Pharmacogenetics of antidepressant medication intolerance., Am J Psychiatry, 160, 1830, 10.1176/appi.ajp.160.10.1830

Lerer, 2002, Pharmacogenetics of tardive dyskinesia: combined analysis of 780 patients supports association with dopamine D3 receptor gene Ser9Gly polymorphism., Neuropsychopharmacology, 27, 105, 10.1016/S0893-133X(02)00293-2

Eichhammer, 2000, Association of dopamine D3-receptor gene variants with neuroleptic induced akathisia in schizophrenic patients: a generalization of Steen's study on DRD3 and tardive dyskinesia., Am J Med Genet, 96, 187, 10.1002/(SICI)1096-8628(20000403)96:2<187::AID-AJMG13>3.0.CO;2-8

Heim, 1990, Genotyping of poor metabolisers of debrisoquine by allele-specific PCR amplification., Lancet, 336, 529, 10.1016/0140-6736(90)92086-W

Lundqvist, 1999, Genetic mechanisms for duplication and multiduplication of the human CYP2D6 gene and methods for detection of duplicated CYP2D6 genes., Gene, 226, 327, 10.1016/S0378-1119(98)00567-8

Yasar, 1999, Validation of methods for CYP2C9 genotyping: frequencies of mutant alleles in a Swedish population. published correction appears in Biochem Biophys Res Commun 1999;258:227 Biochem Biophys Res Commun., , 254, 628

de Morais, 1994, Identification of a new genetic defect responsible for the polymorphism of (S)-mephenytoin metabolism in Japanese., Mol Pharmacol, 46, 594

Chang, 1995, Use of omeprazole as a probe drug for CYP2C19 phenotype in Swedish Caucasians: comparison with S-mephenytoin hydroxylation phenotype and CYP2C19 genotype., Pharmacogenetics, 5, 358, 10.1097/00008571-199512000-00004

Gelernter, 1997, Serotonin transporter protein (SLC6A4) allele and haplotype frequencies and linkage disequilibria in African- and European-American and Japanese populations and in alcohol-dependent subjects., Hum Genet, 101, 243, 10.1007/s004390050624

Erdmann, 1996, Systematic screening for mutations in the human serotonin-2A (5-HT2A) receptor gene: identification of two naturally occurring receptor variants and association analysis in schizophrenia., Hum Genet, 97, 614, 10.1007/BF02281871

Vandenbergh, 1992, Human dopamine transporter gene (DAT1) maps to chromosome 5p15.3 and displays a VNTR., Genomics, 14, 1104, 10.1016/S0888-7543(05)80138-7

Grandy, 1989, The human dopamine D2 receptor gene is located on chromosome 11 at q22-q23 and identifies a TaqI RFLP., Am J Hum Genet, 45, 778

Steen, 1997, Dopamine D3-receptor gene variant and susceptibility to tardive dyskinesia in schizophrenic patients., Mol Psychiatry, 2, 139, 10.1038/sj.mp.4000249

Bertilsson, 2002, Molecular genetics of CYP2D6: clinical relevance with focus on psychotropic drugs., Br J Clin Pharmacol, 53, 111, 10.1046/j.0306-5251.2001.01548.x

Bertilsson, 1995, Geographical/interracial differences in polymorphic drug oxidation. Current state of knowledge of cytochromes P450 (CYP) 2D6 and 2C19., Clin Pharmacokinet, 29, 192, 10.2165/00003088-199529030-00005

Chabane, 2004, Lack of evidence for association between serotonin transporter gene (5-HTTLPR) and obsessive-compulsive disorder by case control and family association study in humans., Neurosci Lett, 363, 154, 10.1016/j.neulet.2004.03.065

Cavallini, 2000, An association study between 5-HTTLPR polymorphism, COMT polymorphism, and Tourette's syndrome., Psychiatry Res, 97, 93, 10.1016/S0165-1781(00)00220-1

Willeit, 2003, A polymorphism (5-HTTLPR) in the serotonin transporter promoter gene is associated with DSM-IV depression subtypes in seasonal affective disorder., Mol Psychiatry, 8, 942, 10.1038/sj.mp.4001392

Mendlewicz, 2004, Serotonin transporter 5HTTLPR polymorphism and affective disorders: no evidence of association in a large European multicenter study., Eur J Hum Genet, 12, 377, 10.1038/sj.ejhg.5201149

Benedetti, 2003, Antidepressant effects of light therapy combined with sleep deprivation are influenced by a functional polymorphism within the promoter of the serotonin transporter gene., Biol Psychiatry, 54, 687, 10.1016/S0006-3223(02)01894-2

Erdmann, 1996, Systematic screening for mutations in the human serotonin-2A (5-HT2A) receptor gene: identification of two naturally occurring receptor variants and association analysis in schizophrenia., Hum Genet, 97, 614, 10.1007/BF02281871

Hemmings, 2003, Investigating the role of dopaminergic and serotonergic candidate genes in obsessive-compulsive disorder., Eur Neuropsychopharmacol, 13, 93, 10.1016/S0924-977X(02)00129-3

de Quervain, 2003, A functional genetic variation of the 5-HT2a receptor affects human memory., Nat Neurosci, 6, 1141, 10.1038/nn1146

Gelernter, 1998, Population studies of polymorphisms at loci of neuropsychiatric interest (tryptophan hydroxylase (TPH), dopamine transporter protein (SLC6A3), D3 dopamine receptor (DRD3), apolipoprotein E (APOE), mu opioid receptor (OPRM1), and ciliary neurotrophic factor (CNTF))., Genomics, 52, 289, 10.1006/geno.1998.5454

Grevle, 2000, Allelic association between the DRD2 TaqI A polymorphism and Parkinson's disease., Mov Disord, 15, 1070, 10.1002/1531-8257(200011)15:6<1070::AID-MDS1003>3.0.CO;2-A

Savoye, 1998, No association between dopamine D1, D2, and D3 receptor genes and manic-depressive illness., Biol Psychiatry, 44, 644, 10.1016/S0006-3223(97)00441-1

Oliveri, 2000, The dopamine D2 receptor gene is a susceptibility locus for Parkinson's disease., Mov Disord, 15, 127, 10.1002/1531-8257(200001)15:1<120::AID-MDS1019>3.0.CO;2-S

Jonsson, 1993, Lack of association between schizophrenia and alleles in the dopamine D3 receptor gene., Acta Psychiatr Scand, 87, 345, 10.1111/j.1600-0447.1993.tb03384.x

Krebs, 1998, Dopamine D3 receptor gene variants and substance abuse in schizophrenia., Mol Psychiatry, 3, 337, 10.1038/sj.mp.4000411

Caligiuri, 2000, Antipsychotic-induced movement disorders in the elderly: epidemiology and treatment recommendations., Drugs Aging, 17, 363, 10.2165/00002512-200017050-00004

Coulter, 1995, Fluoxetine and extrapyramidal side effects., Am J Psychiatry, 152, 122, 10.1176/ajp.152.1.122

Mihara, 2000, No relationship between Taq1 a polymorphism of dopamine D(2) receptor gene and extrapyramidal adverse effects of selective dopamine D(2) antagonists, bromperidol, and nemonapride in schizophrenia: a preliminary study., Am J Med Genet, 96, 422, 10.1002/1096-8628(20000612)96:3<422::AID-AJMG35>3.0.CO;2-5

Kaiser, 2002, Relationship between adverse effects of antipsychotic treatment and dopamine D(2) receptor polymorphisms in patients with schizophrenia., Mol Psychiatry, 7, 695, 10.1038/sj.mp.4001054

Noble, 2003, D2 dopamine receptor gene in psychiatric and neurologic disorders and its phenotypes., Am J Med Genet B Neuropsychiatr Genet, 116, 103, 10.1002/ajmg.b.10005